Literature DB >> 10574102

HLA-DR expression in acute pancreatitis.

A Richter1, T Nebe, K Wendl, K Schuster, G Klaebisch, M Quintel, D Lorenz, S Post, M Trede.   

Abstract

OBJECTIVE: To investigate the role of the monocyte/macrophage system in acute pancreatitis
DESIGN: Prospective clinical study
SETTING: University clinic, Germany SUBJECT: 37 consecutive patients who presented with acute pancreatitis. MAIN OUTCOME MEASURE: Correlation between function of monocytes measured by HLA-DR expression and outcome
RESULTS: Patients were divided into three groups according to outcome: those with severe pancreatitis who died (n = 10), those with severe pancreatitis who survived (n = 15), and those with mild pancreatitis who survived (n = 12). There was a clear and significant difference between those with severe and those with mild disease. HLA-DR expression was initially depressed in both groups, but after the third day of treatment it started to recover significantly in those with mild disease (p < 0.05). The difference was also significant from day 7 onwards between those with severe disease who died and those with severe disease who survived (p < 0.05).
CONCLUSION: Monocyte function as measured by HLA-DR expression (CD14+DR+) is reduced in patients with acute pancreatitis and does not recover in patients who are going to die (median < 20 relative antigen density units; RU).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10574102     DOI: 10.1080/110241599750008053

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  11 in total

1.  Thymosin alpha 1 is associated with improved cellular immunity and reduced infection rate in severe acute pancreatitis patients in a double-blind randomized control study.

Authors:  Xinying Wang; Weiqin Li; Chenglin Niu; Liya Pan; Ning Li; Jieshou Li
Journal:  Inflammation       Date:  2011-06       Impact factor: 4.092

Review 2.  Immunomodulatory therapies for acute pancreatitis.

Authors:  Jing Li; Wen-Juan Yang; Lu-Ming Huang; Cheng-Wei Tang
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 3.  Immune-modulating therapy in acute pancreatitis: fact or fiction.

Authors:  Karolina Akinosoglou; Charalambos Gogos
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

Review 4.  Inflammation and immunosuppression in severe acute pancreatitis.

Authors:  Marja-Leena Kylänpää; Heikki Repo; Pauli Antero Puolakkainen
Journal:  World J Gastroenterol       Date:  2010-06-21       Impact factor: 5.742

5.  Differential down-regulation of HLA-DR on monocyte subpopulations during systemic inflammation.

Authors:  Oh Yoen Kim; Antoine Monsel; Michèle Bertrand; Pierre Coriat; Jean-Marc Cavaillon; Minou Adib-Conquy
Journal:  Crit Care       Date:  2010-04-13       Impact factor: 9.097

Review 6.  Complex role for the immune system in initiation and progression of pancreatic cancer.

Authors:  Kristin S Inman; Amanda A Francis; Nicole R Murray
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

7.  Acute pancreatitis with organ dysfunction associates with abnormal blood lymphocyte signaling: controlled laboratory study.

Authors:  Jani Oiva; Harri Mustonen; Marja-Leena Kylänpää; Lea Kyhälä; Krista Kuuliala; Sanna Siitonen; Esko Kemppainen; Pauli Puolakkainen; Heikki Repo
Journal:  Crit Care       Date:  2010-11-18       Impact factor: 9.097

8.  Activated Protein C Does Not Alleviate the Course of Systemic Inflammation in the APCAP Trial.

Authors:  Lea Kyhälä; Panu Mentula; Leena Kylänpää; Eeva Moilanen; Pauli Puolakkainen; Ville Pettilä; Heikki Repo
Journal:  Int J Inflam       Date:  2012-05-08

9.  The clinical course of acute pancreatitis and the inflammatory mediators that drive it.

Authors:  Leena Kylänpää; Zoltán Rakonczay; Derek A O'Reilly
Journal:  Int J Inflam       Date:  2012-12-12

10.  Development of a Modular Assay for Detailed Immunophenotyping of Peripheral Human Whole Blood Samples by Multicolor Flow Cytometry.

Authors:  Paul F Rühle; Rainer Fietkau; Udo S Gaipl; Benjamin Frey
Journal:  Int J Mol Sci       Date:  2016-08-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.